Striebel H W, Hackenberger J
Klinik für Anaesthesiologie und operative Intensivmedizin, Freie Universität, Berlin.
Anaesthesist. 1992 Jun;41(6):354-60.
Postoperative pain management is still a grossly neglected field. In most cases, antipyretic analgesics alone are insufficient during the early postoperative period. Powerful narcotics are often avoided or underdosed because they are associated with the risk of respiratory depression. Some authors recommend combined infusion of tramadol and metamizole, which is assumed to provide sufficient pain relief without the risk of respiratory depression. However, this regimen has not yet been investigated in a study that meets currently accepted scientific standards. METHODS. Sixty patients who underwent vaginal hysterectomy were included in a randomised, prospective double-blind study. Thirty women received two placebo suppositories immediately after induction of anaesthesia and a postoperative infusion of tramadol and metamizole (400 mg tramadol plus 5 g [= 10 ml] metamizole in 500 ml electrolyte solution). The 30 women of the control group received two ibuprofen suppositories (585.2 mg) preoperatively and a post-operative tramadol infusion (400 mg tramadol plus 10 ml placebo [NaCl 0.9%] in 500 mg electrolyte solution). The patients of both groups received 125 ml of the appropriate infusion solution as a loading dose over 10 min (corresponding to 1.25 mg metamizole and 100 mg tramadol in the metamizole/tramadol group or 100 mg tramadol in the ibuprofen/tramadol group) 10 min after awakening. The remaining solution was administered at an infusion rate of 12.5-25 ml/h (corresponding to 125-250 mg metamizole and 10-20 mg tramadol/h or 10-20 mg tramadol/h). On request or when complaining of stronger pain, the patients received an additional bolus infusion of 125 ml over 10 min. In case of insufficient pain reduction despite repeated infusion of 125-ml boli or consumption of the entire infusion solution, the patients discontinued the study and received demand-adapted intravenous titration of piritramide. Postoperative pain was evaluated on the visual analogue scale (VAS) and the 101-point numerical rating scale immediately before the start of the infusion. Pain evaluation was repeated 20, 30, 40, 60, 100, 120, and 240 min after awakening accompanied by registration of heart rate, respiratory rate, systolic and diastolic blood pressure, and side effects. RESULTS. About 60% of the entire infusion solution was administered within 60 min in both groups. Significant postoperative pain reduction in both groups and on both the 101-point scale and the VAS was observed only at 100, 120, and 240 min after awakening. In the tramadol/metamizole group, nausea occurred in 7 cases and vomiting in 1. Nine patients in this group additionally required intravenous piritramide because of insufficient pain relief. In the tramadol/ibuprofen group, 8 patients complained about nausea and 4 patients vomited. Six patients additionally received intravenous piritramide because of insufficient pain reduction. CONCLUSIONS. Satisfactory pain reduction occurred rather late despite high doses of both the tramadol/metamizole and the tramadol/ibuprofen. Both analgesic combination must be regarded as insufficient after inhalational anaesthesia because of the very slow onset of action and the high failure rate.
术后疼痛管理仍然是一个严重被忽视的领域。在大多数情况下,仅使用解热镇痛药在术后早期是不够的。强效麻醉药常常被避免使用或剂量不足,因为它们存在呼吸抑制的风险。一些作者推荐联合输注曲马多和安乃近,认为这样能在不产生呼吸抑制风险的情况下提供足够的疼痛缓解。然而,这一治疗方案尚未在符合当前公认科学标准的研究中得到验证。方法:60例行阴道子宫切除术的患者被纳入一项随机、前瞻性双盲研究。30名女性在麻醉诱导后立即接受两枚安慰剂栓剂,并在术后输注曲马多和安乃近(400毫克曲马多加5克[=10毫升]安乃近于500毫升电解质溶液中)。对照组的30名女性在术前接受两枚布洛芬栓剂(585.2毫克),并在术后输注曲马多(400毫克曲马多加10毫升安慰剂[0.9%氯化钠]于500毫克电解质溶液中)。两组患者在苏醒后10分钟内均接受125毫升相应的输注溶液作为负荷剂量(在安乃近/曲马多组相当于1.25毫克安乃近和100毫克曲马多,在布洛芬/曲马多组相当于100毫克曲马多)。剩余溶液以12.5 - 25毫升/小时的输注速度给药(在安乃近/曲马多组相当于125 - 250毫克安乃近和10 - 20毫克曲马多/小时,在布洛芬/曲马多组相当于10 - 20毫克曲马多/小时)。应患者要求或当患者主诉疼痛加剧时,患者在10分钟内额外接受125毫升的推注输注。如果尽管重复输注125毫升推注或用完整个输注溶液后疼痛缓解仍不足,患者则停止研究并接受按需调整的静脉注射匹利卡明滴定。在输注开始前,使用视觉模拟评分法(VAS)和101点数字评分法对术后疼痛进行评估。在苏醒后20、30、40、60、100、120和240分钟重复进行疼痛评估,并记录心率、呼吸频率、收缩压和舒张压以及副作用。结果:两组中约60%的整个输注溶液在60分钟内给药。仅在苏醒后100、120和240分钟时,两组在101点量表和VAS上均观察到术后疼痛显著减轻。在曲马多/安乃近组中,7例出现恶心,1例出现呕吐。该组中有9名患者因疼痛缓解不足还需要静脉注射匹利卡明。在曲马多/布洛芬组中,8名患者主诉恶心,4名患者呕吐。6名患者因疼痛减轻不足还额外接受了静脉注射匹利卡明。结论:尽管曲马多/安乃近和曲马多/布洛芬均使用了高剂量,但疼痛减轻令人满意的情况出现得相当晚。由于起效非常缓慢且失败率高,这两种镇痛组合在吸入麻醉后都应被视为不足。